Review



phosphorylated marcks  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc phosphorylated marcks
    A Accumulation of MAPK, PI3K/AKT, YAP and PKC signalling effectors including total and <t>phosphorylated</t> DUSP6, <t>MARCKS,</t> ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 10 nM Trametinib (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. . B Expression levels of pS6 and DUSP6 (normalised to total S6 or REVERT staining, respectively) in vehicle control or 10 nM Trametinib-treated GNAQ/GNA11 -mutant (solid dot) or wild-type (crossed dot) UM cell lines. Data derived from three independent biological experiments ( n = 3), and P values were calculated using paired t tests. ns not significant. C Percentage of cells undergoing S-phase inhibition (dotted line set at 50% S-phase inhibition) and change in % sub-G1 (dotted line set at 30% sub-G1) in GNAQ/GNA11 -mutant (solid circle) or wild-type (crossed circle) UM cell lines treated with 5 µM IDE196 (data derived from ), 10 nM Trametinib or 2 µM BEZ235. Data derived from three independent biological experiments ( n = 3).
    Phosphorylated Marcks, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 124 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated marcks/product/Cell Signaling Technology Inc
    Average 94 stars, based on 124 article reviews
    phosphorylated marcks - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma"

    Article Title: PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma

    Journal: Oncogenesis

    doi: 10.1038/s41389-024-00511-8

    A Accumulation of MAPK, PI3K/AKT, YAP and PKC signalling effectors including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 10 nM Trametinib (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. . B Expression levels of pS6 and DUSP6 (normalised to total S6 or REVERT staining, respectively) in vehicle control or 10 nM Trametinib-treated GNAQ/GNA11 -mutant (solid dot) or wild-type (crossed dot) UM cell lines. Data derived from three independent biological experiments ( n = 3), and P values were calculated using paired t tests. ns not significant. C Percentage of cells undergoing S-phase inhibition (dotted line set at 50% S-phase inhibition) and change in % sub-G1 (dotted line set at 30% sub-G1) in GNAQ/GNA11 -mutant (solid circle) or wild-type (crossed circle) UM cell lines treated with 5 µM IDE196 (data derived from ), 10 nM Trametinib or 2 µM BEZ235. Data derived from three independent biological experiments ( n = 3).
    Figure Legend Snippet: A Accumulation of MAPK, PI3K/AKT, YAP and PKC signalling effectors including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 10 nM Trametinib (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. . B Expression levels of pS6 and DUSP6 (normalised to total S6 or REVERT staining, respectively) in vehicle control or 10 nM Trametinib-treated GNAQ/GNA11 -mutant (solid dot) or wild-type (crossed dot) UM cell lines. Data derived from three independent biological experiments ( n = 3), and P values were calculated using paired t tests. ns not significant. C Percentage of cells undergoing S-phase inhibition (dotted line set at 50% S-phase inhibition) and change in % sub-G1 (dotted line set at 30% sub-G1) in GNAQ/GNA11 -mutant (solid circle) or wild-type (crossed circle) UM cell lines treated with 5 µM IDE196 (data derived from ), 10 nM Trametinib or 2 µM BEZ235. Data derived from three independent biological experiments ( n = 3).

    Techniques Used: Control, Western Blot, Staining, Expressing, Mutagenesis, Derivative Assay, Inhibition

    A Fold change in DUSP6 and pS6 expression (normalised log 2 protein expression in drug-treated – normalised log 2 protein expression in control-treated cells) in GNAQ/GNA11 -mutant (solid circle) and wild-type (crossed circle) UM cell lines treated with 5 µM IDE196, 10 nM Trametinib, or 2 µM BEZ235. Data compared using one-way ANOVA with the Geisser–Greenhouse correction and Tukey’s multiple comparison test, adjusted P values are shown. Data derived from three independent biological experiments ( n = 3, mean ± SD). B Accumulation of MAPK, PI3K, YAP and PKC signalling effectors, including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 2 µM BEZ235 (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. .
    Figure Legend Snippet: A Fold change in DUSP6 and pS6 expression (normalised log 2 protein expression in drug-treated – normalised log 2 protein expression in control-treated cells) in GNAQ/GNA11 -mutant (solid circle) and wild-type (crossed circle) UM cell lines treated with 5 µM IDE196, 10 nM Trametinib, or 2 µM BEZ235. Data compared using one-way ANOVA with the Geisser–Greenhouse correction and Tukey’s multiple comparison test, adjusted P values are shown. Data derived from three independent biological experiments ( n = 3, mean ± SD). B Accumulation of MAPK, PI3K, YAP and PKC signalling effectors, including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 2 µM BEZ235 (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. .

    Techniques Used: Expressing, Control, Mutagenesis, Comparison, Derivative Assay, Western Blot, Staining



    Similar Products

    93
    TargetMol phosphorylated proteins
    Phosphorylated Proteins, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated proteins/product/TargetMol
    Average 93 stars, based on 1 article reviews
    phosphorylated proteins - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Proteintech phosphorylation
    Phosphorylation, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylation/product/Proteintech
    Average 93 stars, based on 1 article reviews
    phosphorylation - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc phosphorylated marcks
    A Accumulation of MAPK, PI3K/AKT, YAP and PKC signalling effectors including total and <t>phosphorylated</t> DUSP6, <t>MARCKS,</t> ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 10 nM Trametinib (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. . B Expression levels of pS6 and DUSP6 (normalised to total S6 or REVERT staining, respectively) in vehicle control or 10 nM Trametinib-treated GNAQ/GNA11 -mutant (solid dot) or wild-type (crossed dot) UM cell lines. Data derived from three independent biological experiments ( n = 3), and P values were calculated using paired t tests. ns not significant. C Percentage of cells undergoing S-phase inhibition (dotted line set at 50% S-phase inhibition) and change in % sub-G1 (dotted line set at 30% sub-G1) in GNAQ/GNA11 -mutant (solid circle) or wild-type (crossed circle) UM cell lines treated with 5 µM IDE196 (data derived from ), 10 nM Trametinib or 2 µM BEZ235. Data derived from three independent biological experiments ( n = 3).
    Phosphorylated Marcks, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated marcks/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    phosphorylated marcks - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Millipore rabbit polyclonal anti-phosphorylated marcks (pser 152/156 , anti-phospho-marcks) antibody
    A Accumulation of MAPK, PI3K/AKT, YAP and PKC signalling effectors including total and <t>phosphorylated</t> DUSP6, <t>MARCKS,</t> ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 10 nM Trametinib (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. . B Expression levels of pS6 and DUSP6 (normalised to total S6 or REVERT staining, respectively) in vehicle control or 10 nM Trametinib-treated GNAQ/GNA11 -mutant (solid dot) or wild-type (crossed dot) UM cell lines. Data derived from three independent biological experiments ( n = 3), and P values were calculated using paired t tests. ns not significant. C Percentage of cells undergoing S-phase inhibition (dotted line set at 50% S-phase inhibition) and change in % sub-G1 (dotted line set at 30% sub-G1) in GNAQ/GNA11 -mutant (solid circle) or wild-type (crossed circle) UM cell lines treated with 5 µM IDE196 (data derived from ), 10 nM Trametinib or 2 µM BEZ235. Data derived from three independent biological experiments ( n = 3).
    Rabbit Polyclonal Anti Phosphorylated Marcks (Pser 152/156 , Anti Phospho Marcks) Antibody, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-phosphorylated marcks (pser 152/156 , anti-phospho-marcks) antibody/product/Millipore
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-phosphorylated marcks (pser 152/156 , anti-phospho-marcks) antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc primary antibodies specific for phosphorylated (p)-marcks (ser167/170; d13e4 xp)
    ROS production is suppressed by <t>PKCβ</t> KO and PKC inhibitor Staurosporine, <t>and</t> <t>MARCKS</t> level and Ser167/170 phosphorylation are not affected in PKCβ KO cells. THP-1-derived PKCβ KO cells (generated using the CRISPR/Cas9 technique) and THP-1 WT cells were differentiated with 100 nM calcitriol for 5 d. Subsequently, ROS production was induced by PMA (100 nM) and determined (in RLU/s) via luminol-amplified chemiluminescence. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 60 min following stimulation ( B ) of total ROS generated by differentiated THP-1 WT and PKCβ KO cells (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 60 min following stimulation ( D ) of intracellular ROS generated by differentiated THP-1 and PKCβ KO cells (representative experiment, n = 3). ( E ) Primary human monocytes were incubated in medium with Staurosprine (Stauro; 80 nM) for 2.5 h. Subsequently, PMA-induced total ROS production was assessed and depicted as cumulated ROS production within 30 min following stimulation (mean ± SD; n = 2). ( F ) THP-1 WT and PKCβ KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested. Total cell extracts were prepared, and MARCKS ED phosphorylation (Ser167/170) and protein levels were determined (Western Blot; loading control: GAPDH; representative experiment, n = 3).
    Primary Antibodies Specific For Phosphorylated (P) Marcks (Ser167/170; D13e4 Xp), supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies specific for phosphorylated (p)-marcks (ser167/170; d13e4 xp)/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies specific for phosphorylated (p)-marcks (ser167/170; d13e4 xp) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc phosphorylated p marcks
    Generation and characterization of <t>MARCKS</t> KO cells. Monocytic THP-1 cells were modified using the CRISPR/Cas9 technique to generate MARCKS KO cells. The resulting WT, IM, and KO clones were characterized in terms of allelic integrity, MARCKS protein expression, proliferation, monocytic differentiation, cytokine expression, and phagocytosis. ( A ) The table summarizes the condition of the 3 MARCKS alleles in MARCKS WT, IM, and KO clones as determined by Sanger sequencing. ( B ) MARCKS protein levels were detected in whole cell extracts of MARCKS WT, IM, and KO clones. Loading control: GAPDH (representative experiment, n > 3). ( C ) MARCKS WT and KO cells were synchronized for 3 d in minimal growth medium. Afterwards, cells were transferred into standard growth medium and cell numbers were counted daily (mean ± SD, n = 3). ( D ) Following calcitriol-induced differentiation (100 nM) for 3 d, CD14 expression on the cell surface was assessed using flow cytometry (dashed line: isotype control; representative experiment, n > 10). ( E ) Five-day calcitriol-differentiated MARCKS WT and KO cells were incubated with 80 ng/mL TNF for 2 h or 48 h (TNF added at day 3), and the IL-8 mRNA level was determined by qRT-PCR. The IL-8 level in differentiated control cells (i.e., in the absence of TNF) was set as 1 (mean ± SD, representative experiment determined in triplicates; n = 3). ( F ) Five-day differentiated THP-1 as well as MARCKS WT and KO cells were incubated with opsonized eFlour670-labeled bacteria for 1 h (>5 bacteria per cell; mean ± SD, representative experiment, determined in duplicates; n = 4). During the incubation with bacteria, control cells were kept on ice. Phagocytosis was analyzed using flow cytometry. The phagocytic activity (i.e., the geometric mean fluorescence intensity) of living and bacteria-positive cells was calculated, and the value obtained in differentiated MARCKS WT cells was set as 100% (dashed line).
    Phosphorylated P Marcks, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated p marcks/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    phosphorylated p marcks - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    A Accumulation of MAPK, PI3K/AKT, YAP and PKC signalling effectors including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 10 nM Trametinib (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. . B Expression levels of pS6 and DUSP6 (normalised to total S6 or REVERT staining, respectively) in vehicle control or 10 nM Trametinib-treated GNAQ/GNA11 -mutant (solid dot) or wild-type (crossed dot) UM cell lines. Data derived from three independent biological experiments ( n = 3), and P values were calculated using paired t tests. ns not significant. C Percentage of cells undergoing S-phase inhibition (dotted line set at 50% S-phase inhibition) and change in % sub-G1 (dotted line set at 30% sub-G1) in GNAQ/GNA11 -mutant (solid circle) or wild-type (crossed circle) UM cell lines treated with 5 µM IDE196 (data derived from ), 10 nM Trametinib or 2 µM BEZ235. Data derived from three independent biological experiments ( n = 3).

    Journal: Oncogenesis

    Article Title: PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma

    doi: 10.1038/s41389-024-00511-8

    Figure Lengend Snippet: A Accumulation of MAPK, PI3K/AKT, YAP and PKC signalling effectors including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 10 nM Trametinib (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. . B Expression levels of pS6 and DUSP6 (normalised to total S6 or REVERT staining, respectively) in vehicle control or 10 nM Trametinib-treated GNAQ/GNA11 -mutant (solid dot) or wild-type (crossed dot) UM cell lines. Data derived from three independent biological experiments ( n = 3), and P values were calculated using paired t tests. ns not significant. C Percentage of cells undergoing S-phase inhibition (dotted line set at 50% S-phase inhibition) and change in % sub-G1 (dotted line set at 30% sub-G1) in GNAQ/GNA11 -mutant (solid circle) or wild-type (crossed circle) UM cell lines treated with 5 µM IDE196 (data derived from ), 10 nM Trametinib or 2 µM BEZ235. Data derived from three independent biological experiments ( n = 3).

    Article Snippet: Membranes were incubated at 4 °C overnight in primary antibodies diluted in Intercept Blocking Buffer (TBS) (Li-Cor, Lincoln, NE, USA) or Odyssey Blocking Buffer (Li-Cor) with Tween 20 (0.05%), as follows: total MARCKS (1:1000, 2C2, WH0004082M6, Sigma-Aldrich), phosphorylated MARCKS (pMARCKS; Ser 152/156 , 1:1000, 2741 S, Cell Signaling Technology, Danvers, MA, USA), DUSP6 (1:250 or 1:1000, EPR129Y, ab76310, Abcam, Cambridge, UK), total AKT (1:1000, 40D4, 2920S, Cell Signaling Technology), phosphorylated AKT (pAKT; Ser 473 , 1:100, D9E, 4060S, Cell Signaling Technology), pAKT (Ser 473 , 1:500, 736E11, 3787, Cell Signaling Technology), total ribosomal S6 (1:500, 54D2, 2317 S, Cell Signaling Technology), phosphorylated ribosomal S6 (pS6; Ser 235/236 , 1:1000, 2F9, 4856S, Cell Signaling Technology), total YAP (1:500, 1A12, 12395S, Cell Signaling Technology), phosphorylated YAP (pYAP; Ser 127 , 1:2000, 4911, Cell Signaling Technology), total ERK (1:2 000, 137F5, 4695S, Cell Signaling Technology), phosphorylated ERK (pERK; Tyr 204 , 1:250, E-4, SC-7383, Santa Cruz, Dallas, TX, USA), and MEK1/2 (1:500, L38C12, 4694S, Cell Signaling Technology).

    Techniques: Control, Western Blot, Staining, Expressing, Mutagenesis, Derivative Assay, Inhibition

    A Fold change in DUSP6 and pS6 expression (normalised log 2 protein expression in drug-treated – normalised log 2 protein expression in control-treated cells) in GNAQ/GNA11 -mutant (solid circle) and wild-type (crossed circle) UM cell lines treated with 5 µM IDE196, 10 nM Trametinib, or 2 µM BEZ235. Data compared using one-way ANOVA with the Geisser–Greenhouse correction and Tukey’s multiple comparison test, adjusted P values are shown. Data derived from three independent biological experiments ( n = 3, mean ± SD). B Accumulation of MAPK, PI3K, YAP and PKC signalling effectors, including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 2 µM BEZ235 (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. .

    Journal: Oncogenesis

    Article Title: PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma

    doi: 10.1038/s41389-024-00511-8

    Figure Lengend Snippet: A Fold change in DUSP6 and pS6 expression (normalised log 2 protein expression in drug-treated – normalised log 2 protein expression in control-treated cells) in GNAQ/GNA11 -mutant (solid circle) and wild-type (crossed circle) UM cell lines treated with 5 µM IDE196, 10 nM Trametinib, or 2 µM BEZ235. Data compared using one-way ANOVA with the Geisser–Greenhouse correction and Tukey’s multiple comparison test, adjusted P values are shown. Data derived from three independent biological experiments ( n = 3, mean ± SD). B Accumulation of MAPK, PI3K, YAP and PKC signalling effectors, including total and phosphorylated DUSP6, MARCKS, ERK, YAP, S6 and AKT 24 h after treatment with vehicle control (−) or 2 µM BEZ235 (+). Western blot analyses were performed using three independent biological replicates ( n = 3). kD kilodalton. REVERT total protein loading stain is shown in Supplementary Fig. .

    Article Snippet: Membranes were incubated at 4 °C overnight in primary antibodies diluted in Intercept Blocking Buffer (TBS) (Li-Cor, Lincoln, NE, USA) or Odyssey Blocking Buffer (Li-Cor) with Tween 20 (0.05%), as follows: total MARCKS (1:1000, 2C2, WH0004082M6, Sigma-Aldrich), phosphorylated MARCKS (pMARCKS; Ser 152/156 , 1:1000, 2741 S, Cell Signaling Technology, Danvers, MA, USA), DUSP6 (1:250 or 1:1000, EPR129Y, ab76310, Abcam, Cambridge, UK), total AKT (1:1000, 40D4, 2920S, Cell Signaling Technology), phosphorylated AKT (pAKT; Ser 473 , 1:100, D9E, 4060S, Cell Signaling Technology), pAKT (Ser 473 , 1:500, 736E11, 3787, Cell Signaling Technology), total ribosomal S6 (1:500, 54D2, 2317 S, Cell Signaling Technology), phosphorylated ribosomal S6 (pS6; Ser 235/236 , 1:1000, 2F9, 4856S, Cell Signaling Technology), total YAP (1:500, 1A12, 12395S, Cell Signaling Technology), phosphorylated YAP (pYAP; Ser 127 , 1:2000, 4911, Cell Signaling Technology), total ERK (1:2 000, 137F5, 4695S, Cell Signaling Technology), phosphorylated ERK (pERK; Tyr 204 , 1:250, E-4, SC-7383, Santa Cruz, Dallas, TX, USA), and MEK1/2 (1:500, L38C12, 4694S, Cell Signaling Technology).

    Techniques: Expressing, Control, Mutagenesis, Comparison, Derivative Assay, Western Blot, Staining

    ROS production is suppressed by PKCβ KO and PKC inhibitor Staurosporine, and MARCKS level and Ser167/170 phosphorylation are not affected in PKCβ KO cells. THP-1-derived PKCβ KO cells (generated using the CRISPR/Cas9 technique) and THP-1 WT cells were differentiated with 100 nM calcitriol for 5 d. Subsequently, ROS production was induced by PMA (100 nM) and determined (in RLU/s) via luminol-amplified chemiluminescence. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 60 min following stimulation ( B ) of total ROS generated by differentiated THP-1 WT and PKCβ KO cells (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 60 min following stimulation ( D ) of intracellular ROS generated by differentiated THP-1 and PKCβ KO cells (representative experiment, n = 3). ( E ) Primary human monocytes were incubated in medium with Staurosprine (Stauro; 80 nM) for 2.5 h. Subsequently, PMA-induced total ROS production was assessed and depicted as cumulated ROS production within 30 min following stimulation (mean ± SD; n = 2). ( F ) THP-1 WT and PKCβ KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested. Total cell extracts were prepared, and MARCKS ED phosphorylation (Ser167/170) and protein levels were determined (Western Blot; loading control: GAPDH; representative experiment, n = 3).

    Journal: Antioxidants

    Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type

    doi: 10.3390/antiox11081600

    Figure Lengend Snippet: ROS production is suppressed by PKCβ KO and PKC inhibitor Staurosporine, and MARCKS level and Ser167/170 phosphorylation are not affected in PKCβ KO cells. THP-1-derived PKCβ KO cells (generated using the CRISPR/Cas9 technique) and THP-1 WT cells were differentiated with 100 nM calcitriol for 5 d. Subsequently, ROS production was induced by PMA (100 nM) and determined (in RLU/s) via luminol-amplified chemiluminescence. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 60 min following stimulation ( B ) of total ROS generated by differentiated THP-1 WT and PKCβ KO cells (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 60 min following stimulation ( D ) of intracellular ROS generated by differentiated THP-1 and PKCβ KO cells (representative experiment, n = 3). ( E ) Primary human monocytes were incubated in medium with Staurosprine (Stauro; 80 nM) for 2.5 h. Subsequently, PMA-induced total ROS production was assessed and depicted as cumulated ROS production within 30 min following stimulation (mean ± SD; n = 2). ( F ) THP-1 WT and PKCβ KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested. Total cell extracts were prepared, and MARCKS ED phosphorylation (Ser167/170) and protein levels were determined (Western Blot; loading control: GAPDH; representative experiment, n = 3).

    Article Snippet: For protein detection, membranes were incubated (4 °C, overnight) with primary antibodies specific for MARCKS (D88D11 XP ® ), phosphorylated (p)-MARCKS (Ser167/170; D13E4 XP ® ), PKCβ (D3E70), Akt (C67E7), or p-Akt (Thr308; D25E6 XP ® ; Cell Signaling Technology, Danvers, MA, USA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma Aldrich, St. Louis, MO, USA).

    Techniques: Phospho-proteomics, Derivative Assay, Generated, CRISPR, Amplification, Incubation, Western Blot, Control

    Increased monocytic ROS production following TNF long-term preincubation is dependent on MARCKS and PKCβ. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 180 min ( B ) of opsonized bacteria-induced (≥5 bacteria/cell) total ROS generated by 5 d calcitriol-differentiated THP-1 cells following preincubation with 80 ng/mL TNF for 48 h (i.e., added at day 3). Total ROS production was assessed via luminol-amplified chemiluminescence (in RLU/s) (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 180 min ( D ) of opsonized bacteria-induced intracellular ROS generated by differentiated THP-1 cells following TNF preincubation as described in ( A ) (representative experiment, n = 3). ( E , F ) Kinetics ( E ) and the respective cumulated production within 30 min ( F ) of PMA-induced (100 nM) total ROS generated by primary human monocytes following TNF preincubation (80 ng/mL TNF for 48 h; representative experiment, n = 4). ( G ) Cumulated intracellular ROS production in MARCKS WT and KO clones (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3). ( H ) Cumulated intracellular ROS production in THP-1 and PKCβ KO cells (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3).

    Journal: Antioxidants

    Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type

    doi: 10.3390/antiox11081600

    Figure Lengend Snippet: Increased monocytic ROS production following TNF long-term preincubation is dependent on MARCKS and PKCβ. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 180 min ( B ) of opsonized bacteria-induced (≥5 bacteria/cell) total ROS generated by 5 d calcitriol-differentiated THP-1 cells following preincubation with 80 ng/mL TNF for 48 h (i.e., added at day 3). Total ROS production was assessed via luminol-amplified chemiluminescence (in RLU/s) (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 180 min ( D ) of opsonized bacteria-induced intracellular ROS generated by differentiated THP-1 cells following TNF preincubation as described in ( A ) (representative experiment, n = 3). ( E , F ) Kinetics ( E ) and the respective cumulated production within 30 min ( F ) of PMA-induced (100 nM) total ROS generated by primary human monocytes following TNF preincubation (80 ng/mL TNF for 48 h; representative experiment, n = 4). ( G ) Cumulated intracellular ROS production in MARCKS WT and KO clones (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3). ( H ) Cumulated intracellular ROS production in THP-1 and PKCβ KO cells (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3).

    Article Snippet: For protein detection, membranes were incubated (4 °C, overnight) with primary antibodies specific for MARCKS (D88D11 XP ® ), phosphorylated (p)-MARCKS (Ser167/170; D13E4 XP ® ), PKCβ (D3E70), Akt (C67E7), or p-Akt (Thr308; D25E6 XP ® ; Cell Signaling Technology, Danvers, MA, USA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma Aldrich, St. Louis, MO, USA).

    Techniques: Bacteria, Generated, Amplification, Clone Assay, Incubation

    Generation and characterization of MARCKS KO cells. Monocytic THP-1 cells were modified using the CRISPR/Cas9 technique to generate MARCKS KO cells. The resulting WT, IM, and KO clones were characterized in terms of allelic integrity, MARCKS protein expression, proliferation, monocytic differentiation, cytokine expression, and phagocytosis. ( A ) The table summarizes the condition of the 3 MARCKS alleles in MARCKS WT, IM, and KO clones as determined by Sanger sequencing. ( B ) MARCKS protein levels were detected in whole cell extracts of MARCKS WT, IM, and KO clones. Loading control: GAPDH (representative experiment, n > 3). ( C ) MARCKS WT and KO cells were synchronized for 3 d in minimal growth medium. Afterwards, cells were transferred into standard growth medium and cell numbers were counted daily (mean ± SD, n = 3). ( D ) Following calcitriol-induced differentiation (100 nM) for 3 d, CD14 expression on the cell surface was assessed using flow cytometry (dashed line: isotype control; representative experiment, n > 10). ( E ) Five-day calcitriol-differentiated MARCKS WT and KO cells were incubated with 80 ng/mL TNF for 2 h or 48 h (TNF added at day 3), and the IL-8 mRNA level was determined by qRT-PCR. The IL-8 level in differentiated control cells (i.e., in the absence of TNF) was set as 1 (mean ± SD, representative experiment determined in triplicates; n = 3). ( F ) Five-day differentiated THP-1 as well as MARCKS WT and KO cells were incubated with opsonized eFlour670-labeled bacteria for 1 h (>5 bacteria per cell; mean ± SD, representative experiment, determined in duplicates; n = 4). During the incubation with bacteria, control cells were kept on ice. Phagocytosis was analyzed using flow cytometry. The phagocytic activity (i.e., the geometric mean fluorescence intensity) of living and bacteria-positive cells was calculated, and the value obtained in differentiated MARCKS WT cells was set as 100% (dashed line).

    Journal: Antioxidants

    Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type

    doi: 10.3390/antiox11081600

    Figure Lengend Snippet: Generation and characterization of MARCKS KO cells. Monocytic THP-1 cells were modified using the CRISPR/Cas9 technique to generate MARCKS KO cells. The resulting WT, IM, and KO clones were characterized in terms of allelic integrity, MARCKS protein expression, proliferation, monocytic differentiation, cytokine expression, and phagocytosis. ( A ) The table summarizes the condition of the 3 MARCKS alleles in MARCKS WT, IM, and KO clones as determined by Sanger sequencing. ( B ) MARCKS protein levels were detected in whole cell extracts of MARCKS WT, IM, and KO clones. Loading control: GAPDH (representative experiment, n > 3). ( C ) MARCKS WT and KO cells were synchronized for 3 d in minimal growth medium. Afterwards, cells were transferred into standard growth medium and cell numbers were counted daily (mean ± SD, n = 3). ( D ) Following calcitriol-induced differentiation (100 nM) for 3 d, CD14 expression on the cell surface was assessed using flow cytometry (dashed line: isotype control; representative experiment, n > 10). ( E ) Five-day calcitriol-differentiated MARCKS WT and KO cells were incubated with 80 ng/mL TNF for 2 h or 48 h (TNF added at day 3), and the IL-8 mRNA level was determined by qRT-PCR. The IL-8 level in differentiated control cells (i.e., in the absence of TNF) was set as 1 (mean ± SD, representative experiment determined in triplicates; n = 3). ( F ) Five-day differentiated THP-1 as well as MARCKS WT and KO cells were incubated with opsonized eFlour670-labeled bacteria for 1 h (>5 bacteria per cell; mean ± SD, representative experiment, determined in duplicates; n = 4). During the incubation with bacteria, control cells were kept on ice. Phagocytosis was analyzed using flow cytometry. The phagocytic activity (i.e., the geometric mean fluorescence intensity) of living and bacteria-positive cells was calculated, and the value obtained in differentiated MARCKS WT cells was set as 100% (dashed line).

    Article Snippet: For protein detection, membranes were incubated (4 °C, overnight) with primary antibodies specific for MARCKS (D88D11 XP ® ), phosphorylated (p)-MARCKS (Ser167/170; D13E4 XP ® ), PKCβ (D3E70), Akt (C67E7), or p-Akt (Thr308; D25E6 XP ® ; Cell Signaling Technology, Danvers, MA, USA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma Aldrich, St. Louis, MO, USA).

    Techniques: Modification, CRISPR, Clone Assay, Expressing, Sequencing, Control, Flow Cytometry, Incubation, Quantitative RT-PCR, Labeling, Bacteria, Activity Assay, Fluorescence

    PMA-induced ROS production is suppressed in monocytic MARCKS KO cells. ( A – D ) Monocytic THP-1-derived MARCKS WT and KO clones were differentiated with 100 nM calcitriol for 5 d. ROS production was induced by 100 nM PMA and assessed via luminol-amplified chemiluminescence in relative light units per second (RLU/s). ( A , B ) PMA-induced total ROS production is completely abolished in monocytic MARCKS KO cells. Kinetics ( A ) and the respective cumulated total ROS production (i.e., the area under the curve (AUC) within 60 min following PMA stimulation) ( B ) of total ROS production in MARCKS WT and KO clones (representative experiment, n = 3). ( C , D ) PMA-induced intracellular ROS production is strongly inhibited in MARCKS KO and partially reduced in MARCKS IM cells. Kinetics (( C ), representative experiment) and the respective cumulated intracellular ROS production within 60 min following PMA stimulation (( D ), mean ± SD, n = 3) in WT, IM, and KO clones. ( E ) Reconstitution of MARCKS in KO cells restores PMA-induced ROS production. MARCKS KO clones were differentiated with 100 nM calcitriol for 5 d. At day 3, cells were transfected with a MARCKS-expressing vector or the respective vector control (control cells: THP-1, transfection control: EGFP-encoding plasmid). Cumulated ROS production of EGFP-positive (i.e., transfected) cells within 60 min following PMA stimulation was detected by flow cytometry. The ROS production in control-transfected KO cells was set as 1 (mean ± SD, n = 3). The insets show the MARCKS levels in KO and THP-1 cells transfected with the control or the MARCKS expression vector. ( F ) Basal Akt levels are reduced and Akt re-phosphorylation is delayed in MARCKS KO cells. THP-1 WT and MARCKS KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested, and total cell extracts were prepared. Akt phosphorylation (at Thr308) and total Akt levels were determined via Western Blot (loading control: GAPDH; representative experiment, n = 3).

    Journal: Antioxidants

    Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type

    doi: 10.3390/antiox11081600

    Figure Lengend Snippet: PMA-induced ROS production is suppressed in monocytic MARCKS KO cells. ( A – D ) Monocytic THP-1-derived MARCKS WT and KO clones were differentiated with 100 nM calcitriol for 5 d. ROS production was induced by 100 nM PMA and assessed via luminol-amplified chemiluminescence in relative light units per second (RLU/s). ( A , B ) PMA-induced total ROS production is completely abolished in monocytic MARCKS KO cells. Kinetics ( A ) and the respective cumulated total ROS production (i.e., the area under the curve (AUC) within 60 min following PMA stimulation) ( B ) of total ROS production in MARCKS WT and KO clones (representative experiment, n = 3). ( C , D ) PMA-induced intracellular ROS production is strongly inhibited in MARCKS KO and partially reduced in MARCKS IM cells. Kinetics (( C ), representative experiment) and the respective cumulated intracellular ROS production within 60 min following PMA stimulation (( D ), mean ± SD, n = 3) in WT, IM, and KO clones. ( E ) Reconstitution of MARCKS in KO cells restores PMA-induced ROS production. MARCKS KO clones were differentiated with 100 nM calcitriol for 5 d. At day 3, cells were transfected with a MARCKS-expressing vector or the respective vector control (control cells: THP-1, transfection control: EGFP-encoding plasmid). Cumulated ROS production of EGFP-positive (i.e., transfected) cells within 60 min following PMA stimulation was detected by flow cytometry. The ROS production in control-transfected KO cells was set as 1 (mean ± SD, n = 3). The insets show the MARCKS levels in KO and THP-1 cells transfected with the control or the MARCKS expression vector. ( F ) Basal Akt levels are reduced and Akt re-phosphorylation is delayed in MARCKS KO cells. THP-1 WT and MARCKS KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested, and total cell extracts were prepared. Akt phosphorylation (at Thr308) and total Akt levels were determined via Western Blot (loading control: GAPDH; representative experiment, n = 3).

    Article Snippet: For protein detection, membranes were incubated (4 °C, overnight) with primary antibodies specific for MARCKS (D88D11 XP ® ), phosphorylated (p)-MARCKS (Ser167/170; D13E4 XP ® ), PKCβ (D3E70), Akt (C67E7), or p-Akt (Thr308; D25E6 XP ® ; Cell Signaling Technology, Danvers, MA, USA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma Aldrich, St. Louis, MO, USA).

    Techniques: Derivative Assay, Clone Assay, Amplification, Transfection, Expressing, Plasmid Preparation, Control, Flow Cytometry, Phospho-proteomics, Western Blot

    Bacteria-induced total ROS production is markedly inhibited, and intracellular ROS production is completely abolished in MARCKS KO cells. MARCKS WT and KO cells were differentiated with 100 nM calcitriol for 5 d. ROS production induced by opsonized bacteria (bac; >5 bacteria/cell) was assessed via luminol-amplified chemiluminescence in RLU/s. ( A , B ) Kinetics ( A ) and the respective cumulated total ROS production within 180 min ( B ) in MARCKS WT and KO clones following stimulation (representative experiment, n = 4). ( C , D ) Kinetics ( C ) and the respective cumulated intracellular ROS production within 180 min ( D ) in WT and KO clones following stimulation (representative experiment, n = 3).

    Journal: Antioxidants

    Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type

    doi: 10.3390/antiox11081600

    Figure Lengend Snippet: Bacteria-induced total ROS production is markedly inhibited, and intracellular ROS production is completely abolished in MARCKS KO cells. MARCKS WT and KO cells were differentiated with 100 nM calcitriol for 5 d. ROS production induced by opsonized bacteria (bac; >5 bacteria/cell) was assessed via luminol-amplified chemiluminescence in RLU/s. ( A , B ) Kinetics ( A ) and the respective cumulated total ROS production within 180 min ( B ) in MARCKS WT and KO clones following stimulation (representative experiment, n = 4). ( C , D ) Kinetics ( C ) and the respective cumulated intracellular ROS production within 180 min ( D ) in WT and KO clones following stimulation (representative experiment, n = 3).

    Article Snippet: For protein detection, membranes were incubated (4 °C, overnight) with primary antibodies specific for MARCKS (D88D11 XP ® ), phosphorylated (p)-MARCKS (Ser167/170; D13E4 XP ® ), PKCβ (D3E70), Akt (C67E7), or p-Akt (Thr308; D25E6 XP ® ; Cell Signaling Technology, Danvers, MA, USA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma Aldrich, St. Louis, MO, USA).

    Techniques: Bacteria, Amplification, Clone Assay

    ROS production is suppressed by PKCβ KO and PKC inhibitor Staurosporine, and MARCKS level and Ser167/170 phosphorylation are not affected in PKCβ KO cells. THP-1-derived PKCβ KO cells (generated using the CRISPR/Cas9 technique) and THP-1 WT cells were differentiated with 100 nM calcitriol for 5 d. Subsequently, ROS production was induced by PMA (100 nM) and determined (in RLU/s) via luminol-amplified chemiluminescence. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 60 min following stimulation ( B ) of total ROS generated by differentiated THP-1 WT and PKCβ KO cells (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 60 min following stimulation ( D ) of intracellular ROS generated by differentiated THP-1 and PKCβ KO cells (representative experiment, n = 3). ( E ) Primary human monocytes were incubated in medium with Staurosprine (Stauro; 80 nM) for 2.5 h. Subsequently, PMA-induced total ROS production was assessed and depicted as cumulated ROS production within 30 min following stimulation (mean ± SD; n = 2). ( F ) THP-1 WT and PKCβ KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested. Total cell extracts were prepared, and MARCKS ED phosphorylation (Ser167/170) and protein levels were determined (Western Blot; loading control: GAPDH; representative experiment, n = 3).

    Journal: Antioxidants

    Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type

    doi: 10.3390/antiox11081600

    Figure Lengend Snippet: ROS production is suppressed by PKCβ KO and PKC inhibitor Staurosporine, and MARCKS level and Ser167/170 phosphorylation are not affected in PKCβ KO cells. THP-1-derived PKCβ KO cells (generated using the CRISPR/Cas9 technique) and THP-1 WT cells were differentiated with 100 nM calcitriol for 5 d. Subsequently, ROS production was induced by PMA (100 nM) and determined (in RLU/s) via luminol-amplified chemiluminescence. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 60 min following stimulation ( B ) of total ROS generated by differentiated THP-1 WT and PKCβ KO cells (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 60 min following stimulation ( D ) of intracellular ROS generated by differentiated THP-1 and PKCβ KO cells (representative experiment, n = 3). ( E ) Primary human monocytes were incubated in medium with Staurosprine (Stauro; 80 nM) for 2.5 h. Subsequently, PMA-induced total ROS production was assessed and depicted as cumulated ROS production within 30 min following stimulation (mean ± SD; n = 2). ( F ) THP-1 WT and PKCβ KO cells were treated with 100 nM PMA. At the indicated time points, cells were harvested. Total cell extracts were prepared, and MARCKS ED phosphorylation (Ser167/170) and protein levels were determined (Western Blot; loading control: GAPDH; representative experiment, n = 3).

    Article Snippet: For protein detection, membranes were incubated (4 °C, overnight) with primary antibodies specific for MARCKS (D88D11 XP ® ), phosphorylated (p)-MARCKS (Ser167/170; D13E4 XP ® ), PKCβ (D3E70), Akt (C67E7), or p-Akt (Thr308; D25E6 XP ® ; Cell Signaling Technology, Danvers, MA, USA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma Aldrich, St. Louis, MO, USA).

    Techniques: Phospho-proteomics, Derivative Assay, Generated, CRISPR, Amplification, Incubation, Western Blot, Control

    Increased monocytic ROS production following TNF long-term preincubation is dependent on MARCKS and PKCβ. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 180 min ( B ) of opsonized bacteria-induced (≥5 bacteria/cell) total ROS generated by 5 d calcitriol-differentiated THP-1 cells following preincubation with 80 ng/mL TNF for 48 h (i.e., added at day 3). Total ROS production was assessed via luminol-amplified chemiluminescence (in RLU/s) (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 180 min ( D ) of opsonized bacteria-induced intracellular ROS generated by differentiated THP-1 cells following TNF preincubation as described in ( A ) (representative experiment, n = 3). ( E , F ) Kinetics ( E ) and the respective cumulated production within 30 min ( F ) of PMA-induced (100 nM) total ROS generated by primary human monocytes following TNF preincubation (80 ng/mL TNF for 48 h; representative experiment, n = 4). ( G ) Cumulated intracellular ROS production in MARCKS WT and KO clones (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3). ( H ) Cumulated intracellular ROS production in THP-1 and PKCβ KO cells (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3).

    Journal: Antioxidants

    Article Title: MARCKS Is an Essential Regulator of Reactive Oxygen Species Production in the Monocytic Cell Type

    doi: 10.3390/antiox11081600

    Figure Lengend Snippet: Increased monocytic ROS production following TNF long-term preincubation is dependent on MARCKS and PKCβ. ( A , B ) Kinetics ( A ) and the respective cumulated production (i.e., the AUC) within 180 min ( B ) of opsonized bacteria-induced (≥5 bacteria/cell) total ROS generated by 5 d calcitriol-differentiated THP-1 cells following preincubation with 80 ng/mL TNF for 48 h (i.e., added at day 3). Total ROS production was assessed via luminol-amplified chemiluminescence (in RLU/s) (representative experiment, n = 3). ( C , D ) Kinetics ( C ) and the respective cumulated production within 180 min ( D ) of opsonized bacteria-induced intracellular ROS generated by differentiated THP-1 cells following TNF preincubation as described in ( A ) (representative experiment, n = 3). ( E , F ) Kinetics ( E ) and the respective cumulated production within 30 min ( F ) of PMA-induced (100 nM) total ROS generated by primary human monocytes following TNF preincubation (80 ng/mL TNF for 48 h; representative experiment, n = 4). ( G ) Cumulated intracellular ROS production in MARCKS WT and KO clones (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3). ( H ) Cumulated intracellular ROS production in THP-1 and PKCβ KO cells (incubated as in ( A )) within 180 min following stimulation with bacteria (representative experiment, n = 3).

    Article Snippet: For protein detection, membranes were incubated (4 °C, overnight) with primary antibodies specific for MARCKS (D88D11 XP ® ), phosphorylated (p)-MARCKS (Ser167/170; D13E4 XP ® ), PKCβ (D3E70), Akt (C67E7), or p-Akt (Thr308; D25E6 XP ® ; Cell Signaling Technology, Danvers, MA, USA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Sigma Aldrich, St. Louis, MO, USA).

    Techniques: Bacteria, Generated, Amplification, Clone Assay, Incubation